drugset

drugset / Trial / NCT00761371

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

NCT00761371 ↗

Phase 4 Completed 52 enrolled MEDA Pharma GmbH & Co. KG ORION Sante · collab

NaSingle-groupOpen-labelTreatment

Summary

Imiquimod 5% cream in the treatment of external genital or perianal warts in HIV+ patients

Timeline

Start: 2002-08
Primary completion: 2004-02
Completion: 2004-02

Publications

Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonne JP, Dupin N, Mougin C. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study. Br J Dermatol. 2009 Oct;161(4):904-9. doi: 10.1111/j.1365-2133.2009.09210.x. Epub 2009 May 15.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Imiquimod	Other / unclassified	5 %	Topical

Indications